Advancing Clinical Research to Improve Patient Outcomes
At Cetacea Clinical GmbH, we are committed to cultivating a strong Quality Culture across every aspect of our work. Through continuous monitoring and analysis of both quality and productivity, we implement robust corrective and preventive actions (CAPAs) to meet the highest standards and exceed stakeholder expectations.
Our mission is to support ethical, efficient, and compliant clinical trial management—enabling progress in medical research and delivering better outcomes for patients.
Our Core Values
Integrity: We act with honesty, transparency, and adherence to the highest ethical standards.
Initiative: We approach challenges with creativity, foresight, and a proactive mindset.
Respect: We value the contributions and needs of all stakeholders—patients, sites, sponsors, and partners.
Accountability: We take full responsibility for the quality and impact of our work.
Achievement: We are committed to delivering excellence, from first-in-human trials to global operations.
With over two decades of experience in clinical trial operations, Cetacea supports biotechnology and pharmaceutical companies in navigating the complexity of clinical development. Whether you need guidance in trial setup, quality management, or regulatory compliance, our team is ready to support your goals.
We welcome new collaborations and are happy to discuss how we can help bring your clinical research forward.
To learn more about our services and expertise, visit the profile of Cornelia Baumgartner, founder and owner of Cetacea Clinical GmbH pr our webpage www.cetacea.ch.
Company Details
- Founded
- -
- Address
- Fridolinsgasse 8, Moehlin,4313,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.cetacea.ch
- Keywords
- Oncology Trials, Infectious Disease Trials, Study Management, First In Man Studies, Dose Escalation Studies, Phase 1 Studies, Phase 2 Studies, IMP Management, Contracting and Budgeting, Risk Management, Proof of Concept Studies, Phase 3 Studies, working according to ICH-GCP Guidelines, eTMF Management, Sponsor Representative, Regulatory services, Phase 4 Studies, Labeling and relabeling of study medication, Study Monitoring, including the unblining part of the study, Informed Consent Development, Study Plan Development, Protocol development, Trouble shooting in difficult trials, Quality System build and management.
- HQ
- Moehlin
Cetacea Clinical Questions
Cetacea Clinical's website is http://www.cetacea.ch
Cetacea Clinical's LinkedIn profile is https://ch.linkedin.com/company/cetaceaclinical
Cetacea Clinical's industry is
Biotechnology Research
Cetacea Clinical's top competitors are
Visual Pitch 360,
Héphaïstos,
Light Chain Bioscience | Novimmune Sa,
Aridis Pharmaceuticals,
Pfizer,
Alexion Pharmaceuticals, Inc.,
T-Curx Gmbh,
Novartis,
Nbe-Therapeutics Ag,
Mundipharma.
Cetacea Clinical's categories are Biotechnology Research
Cetacea Clinical's founding year is 2022
